Faculty, Staff and Student Publications
Publication Date
10-1-2025
Journal
Current Opinion in Cell Biology
DOI
10.1016/j.ceb.2025.102567
PMID
40663954
PMCID
PMC7617980
PubMedCentral® Posted Date
8-1-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Cancer-associated fibroblasts (CAFs) are a multifunctional cell population of solid tumors that substantially remodel the tumor microenvironment (TME). The combination of single-cell and spatial technologies with elegant mouse models and analysis of patient samples is enabling unprecedented advances in the characterization of CAF origins, heterogeneity, and functions within the TME. As such, the field is now evolving to delineate tissue-specific subpopulations of CAFs, their markers, and the biological context in which each subset presents with a tumor-promoting or a tumor-restraining function. In this timely review, we discuss recent advances in CAF biology in the context of emerging areas of interest in the field of anticancer therapy: immunotherapy, metabolism, and extracellular vesicles. We also highlight the substantial role of CAFs in modulating the immune microenvironment and the recent advances in targeting CAFs for cancer treatment.
Keywords
Humans, Tumor Microenvironment, Cancer-Associated Fibroblasts, Neoplasms, Animals, Extracellular Vesicles, Immunotherapy
Published Open-Access
yes
Recommended Citation
Fernanda G Kugeratski, Emily J Kay, and Sara Zanivan, "Cancer-Associated Fibroblasts As Mediators of Tissue Microenvironment Remodeling in Cancer" (2025). Faculty, Staff and Student Publications. 5201.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/5201
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons